# Winti.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/winti

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.winti.kr/
- Latest round: Seed (Jun 30, 2026)
- Investors on record: 1

## About

Based in South Korea, Winti develops innovative at-home diagnostic kits for health monitoring, empowering individuals with tools for personal health management and reproductive wellness.Winti, founded in 2024 and headquartered in Seoul, South Korea, specializes in personal health diagnostics. The company has executed one deal, with its most recent investment round occurring on June 30, 2026, receiving seed funding from Bluepoint Partners.Winti specializes in innovative at-home diagnostic kits designed to empower individuals to monitor their health conveniently and privately. The company's core offerings include the Winti ASK Semen Detection Kit, which enables users to test for semen presence after sexual activity, and the MSK Male Fertility Diagnostic Kit, aimed at assessing male fertility health. Additionally, Winti provides pH testing kits for women to evaluate vaginal health, serving a diverse clientele concerned with personal health and reproductive wellness. These products are manufactured domestically in South Korea and are primarily sold through direct-to-consumer channels in the South Korean market, with plans to expand internationally. Winti's emphasis on user-friendly solutions addresses common health questions and concerns, promoting proactive health management.Winti operates on a direct-to-consumer sales model, where products are sold through its official online shopping platform. Customers purchase diagnostic kits directly, which typically range in price from approximately 29,800 KRW to 49,800 KRW, depending on the specific product. Revenue is generated through one-time purchases rather than subscriptions or partnerships, allowing for flexibility in customer transactions. In the most recent fiscal year of 2025, Winti reported revenue of KRW 13,557.80 million, primarily driven by its flagship products, including the Winti ASK Semen Detection Kit and the MSK Male Fertility Diagnostic Kit.Winti plans to expand its product offerings by launching additional health diagnostic kits in the upcoming years, aiming to provide even more comprehensive health solutions. The company is targeting international markets for expansion, with plans to enter several Asian countries by 2027. The recent seed funding raised in June 2026 will be directed towards product development and market entry strategies to support these initiatives.

## Funding rounds

- Seed, Jun 30, 2026 — Bluepoint Partners

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed